APO Research
Talk to an analyst

APO RESEARCH · REPORT

CMC Biosafety Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global CMC Biosafety Testing Market Analysis and Forecast 2026-2032

5 June 2026212 pages

Choose your research edition.

Industry ResearchCMC Biosafety Testing Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal CMC Biosafety Testing Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal CMC Biosafety Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal CMC Biosafety Testing Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal CMC Biosafety Testing Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

The global CMC Biosafety Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for CMC Biosafety Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for CMC Biosafety Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for CMC Biosafety Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for CMC Biosafety Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of CMC Biosafety Testing include WuXi Biologics, Wuhan Canvest Biotechnology, Centre Testing International (CTI), Suzhou Liangchen Biotechnology, JADE Biomedical, Standard Testing Group, Sino Tech World Biologicals, Q2 Solutions and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for CMC Biosafety Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of CMC Biosafety Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for CMC Biosafety Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the CMC Biosafety Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global CMC Biosafety Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for CMC Biosafety Testing revenue, projected growth trends, production technology, application and end-user industry.

CMC Biosafety Testing Segment by Company

WuXi Biologics

Wuhan Canvest Biotechnology

Centre Testing International (CTI)

Suzhou Liangchen Biotechnology

JADE Biomedical

Standard Testing Group

Sino Tech World Biologicals

Q2 Solutions

Merck

Charles River Laboratories

Sartorius

Eurofins Scientific

CAS Testing Technical Services

SGS

Samsung Biologics

NTEK

Texcell

Sino Biological

Miracle Points

Suzhou Cefety Bioscience

Zhejiang Hengyu Biological

CMC Biosafety Testing Segment by Type

Raw Materials

Viral Banks

Cell Banks

Others

CMC Biosafety Testing Segment by Application

Pharmaceutical and Biotechnology Companies

CROs and CDMOs

Academic and Research Institutions

CMC Biosafety Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CMC Biosafety Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of CMC Biosafety Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CMC Biosafety Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of CMC Biosafety Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of CMC Biosafety Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, CMC Biosafety Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global CMC Biosafety Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Raw Materials Major Player Table 3. Viral Banks Major Player Table 4. Cell Banks Major Player Table 5. Others Major Player Table 6. Global CMC Biosafety Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical and Biotechnology Companies Major Player Table 8. CROs and CDMOs Major Player Table 9. Academic and Research Institutions Major Player Table 10. CMC Biosafety Testing Industry Trends Table 11. CMC Biosafety Testing Industry Drivers Table 12. CMC Biosafety Testing Industry Opportunities and Challenges Table 13. CMC Biosafety Testing Industry Restraints Table 14. Global CMC Biosafety Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global CMC Biosafety Testing Market Size by Region (2021-2026) & (US$ Million) Table 16. Global CMC Biosafety Testing Market Share by Region (2021-2026) Table 17. Global CMC Biosafety Testing Market Size by Region (2027-2032) & (US$ Million) Table 18. Global CMC Biosafety Testing Market Share by Region (2027-2032) Table 19. Global CMC Biosafety Testing Revenue by Players (US$ Million) & (2021-2026) Table 20. Global CMC Biosafety Testing Revenue Market Share by Players (2021-2026) Table 21. Global CMC Biosafety Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global CMC Biosafety Testing Key Players Headquarters & Area Served Table 23. Global CMC Biosafety Testing Players, Product Type & Application Table 24. Global CMC Biosafety Testing Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global CMC Biosafety Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global CMC Biosafety Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 29. Global CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 30. Global CMC Biosafety Testing Revenue Market Share by Type (2021-2026) Table 31. Global CMC Biosafety Testing Revenue Market Share by Type (2027-2032) Table 32. Global CMC Biosafety Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 34. Global CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 35. Global CMC Biosafety Testing Revenue Market Share by Application (2021-2026) Table 36. Global CMC Biosafety Testing Revenue Market Share by Application (2027-2032) Table 37. WuXi Biologics Company Information Table 38. WuXi Biologics Business Overview Table 39. WuXi Biologics CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. WuXi Biologics CMC Biosafety Testing Product Portfolio Table 41. WuXi Biologics Recent Development Table 42. Wuhan Canvest Biotechnology Company Information Table 43. Wuhan Canvest Biotechnology Business Overview Table 44. Wuhan Canvest Biotechnology CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio Table 46. Wuhan Canvest Biotechnology Recent Development Table 47. Centre Testing International (CTI) Company Information Table 48. Centre Testing International (CTI) Business Overview Table 49. Centre Testing International (CTI) CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio Table 51. Centre Testing International (CTI) Recent Development Table 52. Suzhou Liangchen Biotechnology Company Information Table 53. Suzhou Liangchen Biotechnology Business Overview Table 54. Suzhou Liangchen Biotechnology CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio Table 56. Suzhou Liangchen Biotechnology Recent Development Table 57. JADE Biomedical Company Information Table 58. JADE Biomedical Business Overview Table 59. JADE Biomedical CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. JADE Biomedical CMC Biosafety Testing Product Portfolio Table 61. JADE Biomedical Recent Development Table 62. Standard Testing Group Company Information Table 63. Standard Testing Group Business Overview Table 64. Standard Testing Group CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Standard Testing Group CMC Biosafety Testing Product Portfolio Table 66. Standard Testing Group Recent Development Table 67. Sino Tech World Biologicals Company Information Table 68. Sino Tech World Biologicals Business Overview Table 69. Sino Tech World Biologicals CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio Table 71. Sino Tech World Biologicals Recent Development Table 72. Q2 Solutions Company Information Table 73. Q2 Solutions Business Overview Table 74. Q2 Solutions CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Q2 Solutions CMC Biosafety Testing Product Portfolio Table 76. Q2 Solutions Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Merck CMC Biosafety Testing Product Portfolio Table 81. Merck Recent Development Table 82. Charles River Laboratories Company Information Table 83. Charles River Laboratories Business Overview Table 84. Charles River Laboratories CMC Biosafety Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Charles River Laboratories CMC Biosafety Testing Product Portfolio Table 86. Charles River Laboratories Recent Development Table 87. Sartorius Company Information Table 88. Sartorius Business Overview Table 89. Sartorius CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 90. Sartorius CMC Biosafety Testing Product Portfolio Table 91. Sartorius Recent Development Table 92. Eurofins Scientific Company Information Table 93. Eurofins Scientific Business Overview Table 94. Eurofins Scientific CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 95. Eurofins Scientific CMC Biosafety Testing Product Portfolio Table 96. Eurofins Scientific Recent Development Table 97. CAS Testing Technical Services Company Information Table 98. CAS Testing Technical Services Business Overview Table 99. CAS Testing Technical Services CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 100. CAS Testing Technical Services CMC Biosafety Testing Product Portfolio Table 101. CAS Testing Technical Services Recent Development Table 102. SGS Company Information Table 103. SGS Business Overview Table 104. SGS CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 105. SGS CMC Biosafety Testing Product Portfolio Table 106. SGS Recent Development Table 107. Samsung Biologics Company Information Table 108. Samsung Biologics Business Overview Table 109. Samsung Biologics CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 110. Samsung Biologics CMC Biosafety Testing Product Portfolio Table 111. Samsung Biologics Recent Development Table 112. NTEK Company Information Table 113. NTEK Business Overview Table 114. NTEK CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 115. NTEK CMC Biosafety Testing Product Portfolio Table 116. NTEK Recent Development Table 117. Texcell Company Information Table 118. Texcell Business Overview Table 119. Texcell CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 120. Texcell CMC Biosafety Testing Product Portfolio Table 121. Texcell Recent Development Table 122. Sino Biological Company Information Table 123. Sino Biological Business Overview Table 124. Sino Biological CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 125. Sino Biological CMC Biosafety Testing Product Portfolio Table 126. Sino Biological Recent Development Table 127. Miracle Points Company Information Table 128. Miracle Points Business Overview Table 129. Miracle Points CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 130. Miracle Points CMC Biosafety Testing Product Portfolio Table 131. Miracle Points Recent Development Table 132. Suzhou Cefety Bioscience Company Information Table 133. Suzhou Cefety Bioscience Business Overview Table 134. Suzhou Cefety Bioscience CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 135. Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio Table 136. Suzhou Cefety Bioscience Recent Development Table 137. Zhejiang Hengyu Biological Company Information Table 138. Zhejiang Hengyu Biological Business Overview Table 139. Zhejiang Hengyu Biological CMC Biosafety Testing Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 140. Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio Table 141. Zhejiang Hengyu Biological Recent Development Table 142. North America CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 143. North America CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 144. North America CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 145. North America CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 146. North America CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 147. North America CMC Biosafety Testing Revenue by Country (2021-2026) & (US$ Million) Table 148. North America CMC Biosafety Testing Revenue by Country (US$ Million) & (2027-2032) Table 149. Europe CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 150. Europe CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 151. Europe CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 152. Europe CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 153. Europe CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 154. Europe CMC Biosafety Testing Revenue by Country (2021-2026) & (US$ Million) Table 155. Europe CMC Biosafety Testing Revenue by Country (US$ Million) & (2027-2032) Table 156. China CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 157. China CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 158. China CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 159. China CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 163. Asia CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 164. Asia CMC Biosafety Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia CMC Biosafety Testing Revenue by Region (US$ Million) & (2021-2026) Table 166. Asia CMC Biosafety Testing Revenue by Region (US$ Million) & (2027-2032) Table 167. SAMEA CMC Biosafety Testing Revenue by Type (2021-2026) & (US$ Million) Table 168. SAMEA CMC Biosafety Testing Revenue by Type (2027-2032) & (US$ Million) Table 169. SAMEA CMC Biosafety Testing Revenue by Application (2021-2026) & (US$ Million) Table 170. SAMEA CMC Biosafety Testing Revenue by Application (2027-2032) & (US$ Million) Table 171. SAMEA CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 172. SAMEA CMC Biosafety Testing Revenue by Country (2021-2026) & (US$ Million) Table 173. SAMEA CMC Biosafety Testing Revenue by Country (US$ Million) & (2027-2032) Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. CMC Biosafety Testing Image Figure 2. Global CMC Biosafety Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global CMC Biosafety Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Raw Materials Image Figure 5. Viral Banks Image Figure 6. Cell Banks Image Figure 7. Others Image Figure 8. Global CMC Biosafety Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global CMC Biosafety Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. CROs and CDMOs Image Figure 12. Academic and Research Institutions Image Figure 13. Global CMC Biosafety Testing Market Size (US$ Million) & (2021-2032) Figure 14. Global CMC Biosafety Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global CMC Biosafety Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global CMC Biosafety Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global CMC Biosafety Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global CMC Biosafety Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global CMC Biosafety Testing Revenue Market Share by Type (2021-2032) Figure 21. Global CMC Biosafety Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global CMC Biosafety Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global CMC Biosafety Testing Revenue Market Share by Application (2021-2032) Figure 24. North America CMC Biosafety Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America CMC Biosafety Testing Revenue Share by Type (2021-2032) Figure 26. North America CMC Biosafety Testing Revenue Share by Application (2021-2032) Figure 27. North America CMC Biosafety Testing Revenue Share by Country (2021-2032) Figure 28. United States CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe CMC Biosafety Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe CMC Biosafety Testing Revenue Share by Type (2021-2032) Figure 33. Europe CMC Biosafety Testing Revenue Share by Application (2021-2032) Figure 34. Europe CMC Biosafety Testing Revenue Share by Country (2021-2032) Figure 35. Germany CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China CMC Biosafety Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China CMC Biosafety Testing Revenue Share by Type (2021-2032) Figure 45. China CMC Biosafety Testing Revenue Share by Application (2021-2032) Figure 46. Asia CMC Biosafety Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia CMC Biosafety Testing Revenue Share by Type (2021-2032) Figure 48. Asia CMC Biosafety Testing Revenue Share by Application (2021-2032) Figure 49. Asia CMC Biosafety Testing Revenue Share by Region (2021-2032) Figure 50. Japan CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA CMC Biosafety Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA CMC Biosafety Testing Revenue Share by Type (2021-2032) Figure 58. SAMEA CMC Biosafety Testing Revenue Share by Application (2021-2032) Figure 59. SAMEA CMC Biosafety Testing Revenue Share by Country (2021-2032) Figure 60. Brazil CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt CMC Biosafety Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Raw Materials
  • Viral Banks
  • Cell Banks
  • Others
Applications
  • Pharmaceutical and Biotechnology Companies
  • CROs and CDMOs
  • Academic and Research Institutions
Companies covered
  • WuXi Biologics
  • Wuhan Canvest Biotechnology
  • Centre Testing International (CTI)
  • Suzhou Liangchen Biotechnology
  • JADE Biomedical
  • Standard Testing Group
  • Sino Tech World Biologicals
  • Q2 Solutions
  • Merck
  • Charles River Laboratories
  • Sartorius
  • Eurofins Scientific
  • CAS Testing Technical Services
  • SGS
  • Samsung Biologics
  • NTEK
  • Texcell
  • Sino Biological
  • Miracle Points
  • Suzhou Cefety Bioscience
  • Zhejiang Hengyu Biological

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 CMC Biosafety Testing Market by Type
  3. 1.2.1 Global CMC Biosafety Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Raw Materials
  5. 1.2.3 Viral Banks
  6. 1.2.4 Cell Banks
  7. 1.2.5 Others
  8. 1.3 CMC Biosafety Testing Market by Application
  9. 1.3.1 Global CMC Biosafety Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical and Biotechnology Companies
  11. 1.3.3 CROs and CDMOs
  12. 1.3.4 Academic and Research Institutions
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 CMC Biosafety Testing Market Dynamics
  1. 2.1 CMC Biosafety Testing Industry Trends
  2. 2.2 CMC Biosafety Testing Industry Drivers
  3. 2.3 CMC Biosafety Testing Industry Opportunities and Challenges
  4. 2.4 CMC Biosafety Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global CMC Biosafety Testing Market Perspective (2021-2032)
  2. 3.2 Global CMC Biosafety Testing Growth Trends by Region
  3. 3.2.1 Global CMC Biosafety Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global CMC Biosafety Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global CMC Biosafety Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global CMC Biosafety Testing Revenue by Players
  2. 4.1.1 Global CMC Biosafety Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global CMC Biosafety Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global CMC Biosafety Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global CMC Biosafety Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global CMC Biosafety Testing Key Players Headquarters & Area Served
  7. 4.4 Global CMC Biosafety Testing Players, Product Type & Application
  8. 4.5 Global CMC Biosafety Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global CMC Biosafety Testing Market CR5 and HHI
  11. 4.6.3 2025 CMC Biosafety Testing Tier 1, Tier 2, and Tier 3
5 CMC Biosafety Testing Market Size by Type
  1. 5.1 Global CMC Biosafety Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 5.3 Global CMC Biosafety Testing Revenue Market Share by Type (2021-2032)
6 CMC Biosafety Testing Market Size by Application
  1. 6.1 Global CMC Biosafety Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global CMC Biosafety Testing Revenue by Application (2021-2032)
  3. 6.3 Global CMC Biosafety Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 WuXi Biologics
  2. 7.1.1 WuXi Biologics Company Information
  3. 7.1.2 WuXi Biologics Business Overview
  4. 7.1.3 WuXi Biologics CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 WuXi Biologics CMC Biosafety Testing Product Portfolio
  6. 7.1.5 WuXi Biologics Recent Developments
  7. 7.2 Wuhan Canvest Biotechnology
  8. 7.2.1 Wuhan Canvest Biotechnology Company Information
  9. 7.2.2 Wuhan Canvest Biotechnology Business Overview
  10. 7.2.3 Wuhan Canvest Biotechnology CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Wuhan Canvest Biotechnology CMC Biosafety Testing Product Portfolio
  12. 7.2.5 Wuhan Canvest Biotechnology Recent Developments
  13. 7.3 Centre Testing International (CTI)
  14. 7.3.1 Centre Testing International (CTI) Company Information
  15. 7.3.2 Centre Testing International (CTI) Business Overview
  16. 7.3.3 Centre Testing International (CTI) CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Centre Testing International (CTI) CMC Biosafety Testing Product Portfolio
  18. 7.3.5 Centre Testing International (CTI) Recent Developments
  19. 7.4 Suzhou Liangchen Biotechnology
  20. 7.4.1 Suzhou Liangchen Biotechnology Company Information
  21. 7.4.2 Suzhou Liangchen Biotechnology Business Overview
  22. 7.4.3 Suzhou Liangchen Biotechnology CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Suzhou Liangchen Biotechnology CMC Biosafety Testing Product Portfolio
  24. 7.4.5 Suzhou Liangchen Biotechnology Recent Developments
  25. 7.5 JADE Biomedical
  26. 7.5.1 JADE Biomedical Company Information
  27. 7.5.2 JADE Biomedical Business Overview
  28. 7.5.3 JADE Biomedical CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 JADE Biomedical CMC Biosafety Testing Product Portfolio
  30. 7.5.5 JADE Biomedical Recent Developments
  31. 7.6 Standard Testing Group
  32. 7.6.1 Standard Testing Group Company Information
  33. 7.6.2 Standard Testing Group Business Overview
  34. 7.6.3 Standard Testing Group CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Standard Testing Group CMC Biosafety Testing Product Portfolio
  36. 7.6.5 Standard Testing Group Recent Developments
  37. 7.7 Sino Tech World Biologicals
  38. 7.7.1 Sino Tech World Biologicals Company Information
  39. 7.7.2 Sino Tech World Biologicals Business Overview
  40. 7.7.3 Sino Tech World Biologicals CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sino Tech World Biologicals CMC Biosafety Testing Product Portfolio
  42. 7.7.5 Sino Tech World Biologicals Recent Developments
  43. 7.8 Q2 Solutions
  44. 7.8.1 Q2 Solutions Company Information
  45. 7.8.2 Q2 Solutions Business Overview
  46. 7.8.3 Q2 Solutions CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Q2 Solutions CMC Biosafety Testing Product Portfolio
  48. 7.8.5 Q2 Solutions Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Merck CMC Biosafety Testing Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Charles River Laboratories
  56. 7.10.1 Charles River Laboratories Company Information
  57. 7.10.2 Charles River Laboratories Business Overview
  58. 7.10.3 Charles River Laboratories CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Charles River Laboratories CMC Biosafety Testing Product Portfolio
  60. 7.10.5 Charles River Laboratories Recent Developments
  61. 7.11 Sartorius
  62. 7.11.1 Sartorius Company Information
  63. 7.11.2 Sartorius Business Overview
  64. 7.11.3 Sartorius CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sartorius CMC Biosafety Testing Product Portfolio
  66. 7.11.5 Sartorius Recent Developments
  67. 7.12 Eurofins Scientific
  68. 7.12.1 Eurofins Scientific Company Information
  69. 7.12.2 Eurofins Scientific Business Overview
  70. 7.12.3 Eurofins Scientific CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Eurofins Scientific CMC Biosafety Testing Product Portfolio
  72. 7.12.5 Eurofins Scientific Recent Developments
  73. 7.13 CAS Testing Technical Services
  74. 7.13.1 CAS Testing Technical Services Company Information
  75. 7.13.2 CAS Testing Technical Services Business Overview
  76. 7.13.3 CAS Testing Technical Services CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  77. 7.13.4 CAS Testing Technical Services CMC Biosafety Testing Product Portfolio
  78. 7.13.5 CAS Testing Technical Services Recent Developments
  79. 7.14 SGS
  80. 7.14.1 SGS Company Information
  81. 7.14.2 SGS Business Overview
  82. 7.14.3 SGS CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  83. 7.14.4 SGS CMC Biosafety Testing Product Portfolio
  84. 7.14.5 SGS Recent Developments
  85. 7.15 Samsung Biologics
  86. 7.15.1 Samsung Biologics Company Information
  87. 7.15.2 Samsung Biologics Business Overview
  88. 7.15.3 Samsung Biologics CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  89. 7.15.4 Samsung Biologics CMC Biosafety Testing Product Portfolio
  90. 7.15.5 Samsung Biologics Recent Developments
  91. 7.16 NTEK
  92. 7.16.1 NTEK Company Information
  93. 7.16.2 NTEK Business Overview
  94. 7.16.3 NTEK CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  95. 7.16.4 NTEK CMC Biosafety Testing Product Portfolio
  96. 7.16.5 NTEK Recent Developments
  97. 7.17 Texcell
  98. 7.17.1 Texcell Company Information
  99. 7.17.2 Texcell Business Overview
  100. 7.17.3 Texcell CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Texcell CMC Biosafety Testing Product Portfolio
  102. 7.17.5 Texcell Recent Developments
  103. 7.18 Sino Biological
  104. 7.18.1 Sino Biological Company Information
  105. 7.18.2 Sino Biological Business Overview
  106. 7.18.3 Sino Biological CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Sino Biological CMC Biosafety Testing Product Portfolio
  108. 7.18.5 Sino Biological Recent Developments
  109. 7.19 Miracle Points
  110. 7.19.1 Miracle Points Company Information
  111. 7.19.2 Miracle Points Business Overview
  112. 7.19.3 Miracle Points CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  113. 7.19.4 Miracle Points CMC Biosafety Testing Product Portfolio
  114. 7.19.5 Miracle Points Recent Developments
  115. 7.20 Suzhou Cefety Bioscience
  116. 7.20.1 Suzhou Cefety Bioscience Company Information
  117. 7.20.2 Suzhou Cefety Bioscience Business Overview
  118. 7.20.3 Suzhou Cefety Bioscience CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  119. 7.20.4 Suzhou Cefety Bioscience CMC Biosafety Testing Product Portfolio
  120. 7.20.5 Suzhou Cefety Bioscience Recent Developments
  121. 7.21 Zhejiang Hengyu Biological
  122. 7.21.1 Zhejiang Hengyu Biological Company Information
  123. 7.21.2 Zhejiang Hengyu Biological Business Overview
  124. 7.21.3 Zhejiang Hengyu Biological CMC Biosafety Testing Revenue and Gross Margin (2021-2026)
  125. 7.21.4 Zhejiang Hengyu Biological CMC Biosafety Testing Product Portfolio
  126. 7.21.5 Zhejiang Hengyu Biological Recent Developments
8 North America
  1. 8.1 North America CMC Biosafety Testing Revenue (2021-2032)
  2. 8.2 North America CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America CMC Biosafety Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America CMC Biosafety Testing Revenue by Type (2027-2032)
  5. 8.3 North America CMC Biosafety Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America CMC Biosafety Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America CMC Biosafety Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America CMC Biosafety Testing Revenue by Application (2027-2032)
  9. 8.5 North America CMC Biosafety Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America CMC Biosafety Testing Revenue by Country
  11. 8.6.1 North America CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America CMC Biosafety Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America CMC Biosafety Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe CMC Biosafety Testing Revenue (2021-2032)
  2. 9.2 Europe CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe CMC Biosafety Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe CMC Biosafety Testing Revenue by Type (2027-2032)
  5. 9.3 Europe CMC Biosafety Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe CMC Biosafety Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe CMC Biosafety Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe CMC Biosafety Testing Revenue by Application (2027-2032)
  9. 9.5 Europe CMC Biosafety Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe CMC Biosafety Testing Revenue by Country
  11. 9.6.1 Europe CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe CMC Biosafety Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe CMC Biosafety Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China CMC Biosafety Testing Revenue (2021-2032)
  2. 10.2 China CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 10.2.1 China CMC Biosafety Testing Revenue by Type (2021-2026)
  4. 10.2.2 China CMC Biosafety Testing Revenue by Type (2027-2032)
  5. 10.3 China CMC Biosafety Testing Revenue Share by Type (2021-2032)
  6. 10.4 China CMC Biosafety Testing Revenue by Application (2021-2032)
  7. 10.4.1 China CMC Biosafety Testing Revenue by Application (2021-2026)
  8. 10.4.2 China CMC Biosafety Testing Revenue by Application (2027-2032)
  9. 10.5 China CMC Biosafety Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia CMC Biosafety Testing Revenue (2021-2032)
  2. 11.2 Asia CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia CMC Biosafety Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia CMC Biosafety Testing Revenue by Type (2027-2032)
  5. 11.3 Asia CMC Biosafety Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia CMC Biosafety Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia CMC Biosafety Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia CMC Biosafety Testing Revenue by Application (2027-2032)
  9. 11.5 Asia CMC Biosafety Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia CMC Biosafety Testing Revenue by Country
  11. 11.6.1 Asia CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia CMC Biosafety Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia CMC Biosafety Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA CMC Biosafety Testing Revenue (2021-2032)
  2. 12.2 SAMEA CMC Biosafety Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA CMC Biosafety Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA CMC Biosafety Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA CMC Biosafety Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA CMC Biosafety Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA CMC Biosafety Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA CMC Biosafety Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA CMC Biosafety Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA CMC Biosafety Testing Revenue by Country
  11. 12.6.1 SAMEA CMC Biosafety Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA CMC Biosafety Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA CMC Biosafety Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst